Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ORKA compared with JBIO: revenue, margins and what each company keeps, and the suppliers and customers both name
ORKA
Oruka Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
JBIO
Jade Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ORKA
Oruka Therapeutics, Inc.
vs
JBIO
Jade Biosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ORKA
0
None
Shared
0
No disclosed counterparties: ORKA.
Only JBIO
3
—
Patheon Biologics
unlisted
supplier
—
WuXi Biologics (Hong Kong)
unlisted
supplier
—
WuXi Biologics Ireland
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
ORKA
Oruka Therapeutics, Inc.
Change
102.60
▲
+6.85%
· post 103.19
Mkt cap
$6.8B
JBIO
Jade Biosciences, Inc.
Change
15.06
▲
+6.80%
· post 15.29
Closed
Nov 6 '26
Mkt cap
$958.4M
vs
Compare
Closed
Nov 6 '26
ORKA
Oruka Therapeutics, Inc.
vs
JBIO
Jade Biosciences, Inc.
102.60
▲
+6.85%
post 103.19
Price
15.06
▲
+6.80%
post 15.29
$6.8B
Mkt cap
$958.4M
Change
Change
ORKA
102.60
▲
+6.85%
vs
JBIO
15.06
▲
+6.80%
Closed
Nov 6 '26